Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
2007年11月9日 - 3:36AM
PRニュース・ワイアー (英語)
SOUTH SAN FRANCISCO, Calif., Nov. 8 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that
William D. Young, Chairman and CEO, is scheduled to present a
corporate overview at the Lazard Fourth Annual Healthcare
Conference on Wednesday, November 28, 2007 at 8:00 a.m. (Eastern
Time) at the New York Palace Hotel. To access the live audio
broadcast or the subsequent archived recording, log on to
http://www.monogrambio.com/ and go to the investor relations
section ("Investors/Media" tab) and click on the "Events &
Webcasts" link provided on the sidebar menu on the page. About
Monogram Biosciences, Inc. Monogram is advancing individualized
medicine by discovering, developing and marketing innovative
products to guide and improve treatment of serious infectious
diseases and cancer. The Company's products are designed to help
doctors optimize treatment regimens for their patients that lead to
better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new
and improved antiviral therapeutics and vaccines as well as
targeted cancer therapeutics. More information about the Company
and its technology can be found on its web site at
http://www.monogrambio.com/. contacts: Alfred G. Merriweather
Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700 DATASOURCE: Monogram
Biosciences, Inc. CONTACT: Alfred G. Merriweather, Chief Financial
Officer of Monogram Biosciences, Inc., +1-650-624-4576, , or
Jeremiah Hall of Feinstein Kean Healthcare, +1-415-677-2700, , for
Monogram Biosciences, Inc. Web site: http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 6 2024 まで 7 2024
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 7 2023 まで 7 2024